Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

EVT-201 begins second phase II trial for insomnia

Nov. 21, 2006

MethylGene and EnVivo collaborate with CHDI on Huntington's program

Nov. 21, 2006

Roxro's intranasal ketorolac provides effective postsurgery pain relief

Nov. 21, 2006

New agents for treating neurological disorders reported in recent patents

Nov. 20, 2006

New therapeutic agents for schizophrenia, anxiety, etc. disclosed in recent patents

Nov. 20, 2006

European CHMP recommends approval of Inovelon for Lennox-Gastaut syndrome

Nov. 20, 2006

Neupro recommended for approval in E.U. for advanced Parkinson's

Nov. 20, 2006

VEC-162 shows ability to induce and maintain sleep

Nov. 17, 2006

Recent patents report novel analgesic agents

Nov. 16, 2006

Cannasat and IntelGenx to codevelop novel cannabinoid-based products

Nov. 16, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...